Literature DB >> 19386986

Dorsomedial medullary 5-HT2 receptors mediate immediate onset of initial hyperventilation, airway dilation, and ventilatory decline during hypoxia in mice.

Mitsuko Kanamaru1, Ikuo Homma.   

Abstract

The dorsomedial medulla oblongata (DMM) includes the solitary tract nucleus and the hypoglossal nucleus, to which 5-HT neurons project. Effects of 5-HT in the DMM on ventilatory augmentation and airway dilation are mediated via 5-HT2 receptors, which interact with the CO(2) drive. The interaction may elicit cycles between hyperventilation with airway dilation and hypoventilation with airway narrowing. In the present study, effects of 5-HT2 receptors in the DMM on hypoxic ventilatory and airway responses were investigated, while 5-HT release in the DMM was monitored. Adult male mice were anesthetized, and then a microdialysis probe was inserted into the DMM. The mice were placed in a double-chamber plethysmograph. After recovery from anesthesia, the mice were exposed to hypoxic gas (7% O(2) in N(2)) for 5 min with or without a 5-HT2 receptor antagonist (LY-53857) perfused in the DMM. 5-HT release in the DMM was increased by hypoxia regardless of the presence of LY-53857. Immediate onset and the peak of initial hypoxic hyperventilatory responses were delayed. Subsequent ventilatory decline and airway dilation during initial hypoxic hyperventilation were suppressed with LY-53857. These results suggest that 5-HT release increased by hypoxia acts on 5-HT2 receptors in the DMM, which contributes to the immediate onset of initial hypoxic hyperventilation, airway dilation, and subsequent ventilatory decline. Hypoxic ventilatory and airway responses mediated via 5-HT2 receptors in the DMM may play roles in immediate rescue and defensive adaptation for hypoxia and may be included in periodic breathing and the pathogenesis of obstructive sleep apnea.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19386986     DOI: 10.1152/ajpregu.90802.2008

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  7 in total

1.  Effects of dorsomedial medullary 5-HT2 receptor antagonism on initial ventilatory airway responses to hypercapnic hypoxia in mice.

Authors:  Mitsuko Kanamaru; Toshihisa Sugita; Ikuo Homma
Journal:  Exp Brain Res       Date:  2013-03-30       Impact factor: 1.972

2.  The vesicular glutamate transporter VGLUT3 contributes to protection against neonatal hypoxic stress.

Authors:  Stéphanie Miot; Nicolas Voituron; Adélaïde Sterlin; Erika Vigneault; Lydie Morel; Boris Matrot; Nelina Ramanantsoa; Bénédicte Amilhon; Odile Poirel; Eve Lepicard; Salah El Mestikawy; Gérard Hilaire; Jorge Gallego
Journal:  J Physiol       Date:  2012-08-13       Impact factor: 5.182

Review 3.  The role of serotonin in respiratory function and dysfunction.

Authors:  Gérard Hilaire; Nicolas Voituron; Clément Menuet; Ronaldo M Ichiyama; Hari H Subramanian; Mathias Dutschmann
Journal:  Respir Physiol Neurobiol       Date:  2010-08-27       Impact factor: 1.931

4.  Activation of 5-hyrdoxytryptamine 7 receptors within the rat nucleus tractus solitarii modulates synaptic properties.

Authors:  Michael P Matott; David D Kline
Journal:  Brain Res       Date:  2016-01-15       Impact factor: 3.252

5.  Serotoninergic modulation of cortical and respiratory responses to episodic hypoxia.

Authors:  K Budzinska
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

6.  Serotonergic system in hypoxic ventilatory response in unilateral rat model of Parkinson's disease.

Authors:  Kryspin Andrzejewski; Katarzyna Kaczyńska; Małgorzata Zaremba
Journal:  J Biomed Sci       Date:  2017-03-27       Impact factor: 8.410

7.  Deficiency of Biogenic Amines Modulates the Activity of Hypoglossal Nerve in the Reserpine Model of Parkinson's Disease.

Authors:  Monika Jampolska; Kryspin Andrzejewski; Małgorzata Zaremba; Ilona Joniec-Maciejak; Katarzyna Kaczyńska
Journal:  Cells       Date:  2021-03-02       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.